James Quincey, Director, Chairman, on May 07, 2026, sold 200,000 shares in Coca Cola (KO) for $15,780,900. Following the Form 4 filing with the SEC, Quincey has control over a total of 131,876 common shares of the company, with 78,155 shares held directly and 53,721 controlled indirectly.
SEC Filing:
https://www.sec.gov/Archives/edgar/data/21344/000002134426000137/xslF345X05/form4.xml
Price: $78.25, Change: $-0.17, Percent Change: -0.22%
Lynne N. Ward, Director, on May 07, 2026, sold 5,000 shares in Merit Medical Systems (MMSI) for $313,035. Following the Form 4 filing with the SEC, Ward has control over a total of 7,809 common shares of the company, with 7,809 shares held directly.SEC Filing:https://www.sec.gov/Archives/edgar/data/856982/000178612726000002/xslF345X05/form4-05112026_050527.xmlPrice: $60.97, Change: $-0.30, Percent Change: -0.49%
Robert C. Martens, Senior Vice President, Chief Innovation and Design Officer, on May 07, 2026, sold 3,993 shares in Allegion (ALLE) for $547,640. Following the Form 4 filing with the SEC, Martens has control over a total of 8,570 ordinary shares of the company, with 8,570 shares held directly.SEC Filing:https://www.sec.gov/Archives/edgar/data/1579241/000179621526000010/xslF345X05/wk-form4_1778516311.xmlPrice: $133.05, Change: $-1.32, Percent Change: -0.98%
Gianluca Ambrogio Tagliabue, Acting Group CEO, on May 07, 2026, sold 19,105 shares in Ermenegildo Zegna (ZGN) for $250,658. Following the Form 4 filing with the SEC, Tagliabue has control over a total of 167,720 ordinary shares of the company, with 167,720 shares held directly.SEC Filing:https://www.sec.gov/Archives/edgar/data/1877787/000197683726000004/xslF345X05/wk-form4_1778510853.xmlPrice: $12.59, Change: $-0.57, Percent Change: -4.33%